XML 34 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-based Compensation Expense and Share Repurchase
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based Compensation Expense and Share Repurchase
Stock-based Compensation Expense and Share Repurchase
Stock-based compensation expense
During the three months ended March 31, 2019 and 2018, the Company recognized the following stock-based compensation expense:
 
Three Months Ended March 31,
 
2019
 
2018
 
(in thousands)
Stock-based compensation expense by type of award:
 
 
 
Restricted stock and restricted stock units (including PSUs)
$
63,510

 
$
50,418

Stock options
28,156

 
26,055

ESPP share issuances
2,577

 
2,128

Stock-based compensation expense related to inventories
(452
)
 
(465
)
Total stock-based compensation included in costs and expenses
$
93,791

 
$
78,136

 
 
 
 
Stock-based compensation expense by line item:
 
 


Cost of sales
$
1,338

 
$
813

Research and development expenses
59,715

 
48,488

Sales, general and administrative expenses
32,738

 
28,835

Total stock-based compensation included in costs and expenses
93,791

 
78,136

Income tax effect
(39,524
)
 
(21,859
)
Total stock-based compensation included in costs and expenses, net of tax
$
54,267

 
$
56,277


The following table sets forth the Company’s unrecognized stock-based compensation expense as of March 31, 2019, by type of award and the weighted-average period over which that expense is expected to be recognized:
 
As of March 31, 2019
 
Unrecognized Expense
 
Weighted-average
Recognition Period
 
(in thousands)
 
(in years)
Type of award:
 
 
 
Restricted stock and restricted stock units (including PSUs)
$
475,787

 
2.55
Stock options
$
193,321

 
2.84
ESPP share issuances
$
2,555

 
0.43

The following table summarizes information about stock options outstanding and exercisable as of March 31, 2019:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number
Outstanding
 
Weighted-average
Remaining
Contractual Life
 
Weighted-average
Exercise Price
 
Number
Exercisable
 
Weighted-average
Exercise Price
 
 
(in thousands)
 
(in years)
 
(per share)
 
(in thousands)
 
(per share)
$29.07–$40.00
 
252

 
1.67
 
$
35.87

 
252

 
$
35.87

$40.01–$60.00
 
437

 
3.20
 
$
50.23

 
437

 
$
50.23

$60.01–$80.00
 
525

 
5.02
 
$
74.83

 
516

 
$
74.82

$80.01–$100.00
 
2,481

 
6.95
 
$
89.20

 
1,315

 
$
89.81

$100.01–$120.00
 
622

 
5.88
 
$
109.32

 
614

 
$
109.24

$120.01–$140.00
 
773

 
6.36
 
$
130.20

 
653

 
$
130.24

$140.01–$160.00
 
1,287

 
8.82
 
$
155.51

 
333

 
$
155.35

$160.01–$180.00
 
502

 
8.30
 
$
162.94

 
177

 
$
162.95

$180.01–$187.53
 
1,823

 
9.65
 
$
185.29

 
115

 
$
182.72

Total
 
8,702

 
7.28
 
$
124.11

 
4,412

 
$
100.04


Share repurchase program
The Company’s Board of Directors approved a share repurchase program, pursuant to which the Company is authorized to repurchase up to $500.0 million of its common stock between February 1, 2018 and December 31, 2019. Under the share repurchase program, the Company is authorized to purchase shares from time to time through open market or privately negotiated transactions. Such purchases may be made pursuant to Rule 10b5-1 plans or other means as determined by the Company’s management and in accordance with the requirements of the SEC.
During the three months ended March 31, 2019 and 2018, the Company repurchased 537,018 and 67,084 shares, respectively, of its common stock under the share repurchase program for an aggregate of $98.0 million (of which $4.0 million was accrued as of March 31, 2019) and $11.3 million, respectively, including commissions and fees. As of March 31, 2019, there is a total of $52.0 million remaining for repurchases under the share repurchase program. The Company expects to fund further repurchases of its common stock through a combination of cash on hand and cash generated by operations.